Loading clinical trials...

Fibroid Ablation Study | Clinical Trials | Clareo Health

TERMINATEDNANCT01226290

Fibroid Ablation Study

The primary objective of this study is to establish the effectiveness and confirm the safety of the VizAblate System in ablating symptomatic uterine fibroids.

Lead sponsor: Gynesonics•10 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Related studies

RECRUITING

Hereditary Leiomyomatosis Renal Cell Cancer - Study of the Genetic Cause and the Predisposition to Renal Cancer

NCT00050752 · Renal Tumor Histology, Cutaneous Leiomyoma, and more

RECRUITING

A Registry to Gather Real World Use Data on the Cerene® Cryotherapy Device

NCT05922657 · Heavy Menstrual Bleeding, Abnormal Uterine Bleeding, and more

RECRUITINGPhase 3

A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis

NCT05862272 · Uterine Fibroids, Endometriosis

RECRUITINGNA

Effects of Resistance Training Intensity on Cardiovascular Parameters of Hypertensive Women

NCT06538454 · Arterial Hypertension, Postmenopausal; Menorrhagia, and more

RECRUITING

The Genotype and Phenotype of Lymphangioleiomyomatosis

NCT06405997 · Sporadic Lymphangioleiomyomatosis, TSC-associated Lymphangioleiomyomatosis

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 2, 2015Terms

Trial snapshot

StatusTERMINATED

PhaseNA

Enrollment51

Start dateJan 2011

Last updatedApr 2, 2015

Condition

Leiomyoma Uterine Fibroids Menorrhagia

Locations shown

Universidad Autonoma de Nuevo Leon (UANL)

Monterrey, Nuevo León

Máxima Medisch Centrum

Veldhoven, North Brabant

Vrije Universiteit Medisch Centrum

Amsterdam, North Holland

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 2, 2015Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Fibroid Ablation Study

What this study is about

Clareo turns complex medical information into clear understanding you can use.

Sponsors

Related studies

Hereditary Leiomyomatosis Renal Cell Cancer - Study of the Genetic Cause and the Predisposition to Renal Cancer

A Registry to Gather Real World Use Data on the Cerene® Cryotherapy Device

A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis

Effects of Resistance Training Intensity on Cardiovascular Parameters of Hypertensive Women

The Genotype and Phenotype of Lymphangioleiomyomatosis

Trial snapshot

Condition

Locations shown

For caregivers